Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read987 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
Three Years of Tinubu, Manufacturers Say Policies Have Not Delivered Industrial Growth
Three years after President Bola Tinubu assumed office, Nigeria’s manufacturers have delivered...
Gambia and Senegal Seal Landmark Cooperation Agreements Across Defence and Border Management
The Gambia and Senegal have taken a major step forward in their...
INEC in Disgrace as Officials Hand Death Certificates to Voter Registrants
A disturbing administrative blunder at a local office of the Independent National...
Mali and Mauritania Pledge Stronger Bilateral Cooperation in Bamako Meeting
Mali and Mauritania have moved to strengthen their bilateral cooperation following a...